Chih‐Ping Hsu

930 total citations
34 papers, 789 citations indexed

About

Chih‐Ping Hsu is a scholar working on Molecular Biology, Oncology and Biochemistry. According to data from OpenAlex, Chih‐Ping Hsu has authored 34 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Biochemistry. Recurrent topics in Chih‐Ping Hsu's work include Phytochemicals and Antioxidant Activities (9 papers), Natural product bioactivities and synthesis (5 papers) and Tannin, Tannase and Anticancer Activities (4 papers). Chih‐Ping Hsu is often cited by papers focused on Phytochemicals and Antioxidant Activities (9 papers), Natural product bioactivities and synthesis (5 papers) and Tannin, Tannase and Anticancer Activities (4 papers). Chih‐Ping Hsu collaborates with scholars based in Taiwan and United States. Chih‐Ping Hsu's co-authors include Yuan‐Chiang Chung, Chih‐Cheng Lin, Ting‐Yu Kao, Chiu-Chen Huang, Shiaw‐Der Yang, Bor‐Ru Lin, Yu-Jen Chen, Chi‐Chen Fan, King‐Jen Chang and Alan Yueh‐Luen Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of Agricultural and Food Chemistry.

In The Last Decade

Chih‐Ping Hsu

33 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Ping Hsu Taiwan 17 351 184 141 128 114 34 789
Govindaraj Sharmila India 15 508 1.4× 131 0.7× 142 1.0× 163 1.3× 92 0.8× 23 964
Yann Schneider France 13 577 1.6× 162 0.9× 108 0.8× 106 0.8× 181 1.6× 16 1.1k
Elżbieta Hrabec Poland 16 311 0.9× 187 1.0× 106 0.8× 96 0.8× 52 0.5× 29 784
Lokesh Dalasanur Nagaprashantha United States 15 581 1.7× 107 0.6× 164 1.2× 122 1.0× 76 0.7× 23 961
Andrew Hitron United States 7 385 1.1× 140 0.8× 67 0.5× 94 0.7× 57 0.5× 8 751
Mohamed R. Akl United States 17 370 1.1× 141 0.8× 114 0.8× 108 0.8× 45 0.4× 23 862
Marina Orlandi Italy 14 442 1.3× 130 0.7× 87 0.6× 97 0.8× 90 0.8× 26 770
Jing-Pin Lin Taiwan 18 731 2.1× 129 0.7× 159 1.1× 227 1.8× 89 0.8× 20 1.3k
Jae In Jung South Korea 17 548 1.6× 104 0.6× 151 1.1× 97 0.8× 52 0.5× 50 1.0k
Ratana Banjerdpongchai Thailand 19 442 1.3× 76 0.4× 79 0.6× 208 1.6× 71 0.6× 49 917

Countries citing papers authored by Chih‐Ping Hsu

Since Specialization
Citations

This map shows the geographic impact of Chih‐Ping Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Ping Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Ping Hsu more than expected).

Fields of papers citing papers by Chih‐Ping Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Ping Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Ping Hsu. The network helps show where Chih‐Ping Hsu may publish in the future.

Co-authorship network of co-authors of Chih‐Ping Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Ping Hsu. A scholar is included among the top collaborators of Chih‐Ping Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Ping Hsu. Chih‐Ping Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chung, Yuan‐Chiang, Chiu-Chen Huang, Ming‐Tsung Lai, et al.. (2024). Tocilizumab Exerts Anti-Tumor Effects on Colorectal Carcinoma Cell Xenografts Corresponding to Expression Levels of Interleukin-6 Receptor. Pharmaceuticals. 17(1). 127–127. 4 indexed citations
2.
Lin, Chih‐Cheng, et al.. (2023). Synergistic Chemopreventive Effects of a Novel Combined Plant Extract Comprising Gallic Acid and Hesperidin on Colorectal Cancer. Current Issues in Molecular Biology. 45(6). 4908–4922. 5 indexed citations
3.
4.
Kuo, Cheng‐Liang, Han-Yu Chou, Hui‐Wen Lien, et al.. (2022). A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment. Cancer Immunology Immunotherapy. 72(2). 351–369. 12 indexed citations
5.
Chung, Yuan‐Chiang, et al.. (2021). Antibody to Interleukin-6 Receptor InhibitsIn VivoGrowth of Human Colorectal Carcinoma Cell Xenografts. Anticancer Research. 41(10). 4907–4916. 4 indexed citations
6.
Chung, Yuan‐Chiang, et al.. (2018). Longan flower proanthocyanidins induce apoptosis in HT-29 colorectal carcinoma spheroids. Journal of Cancer Research and Therapeutics. 14(Suppl 2). S388–S393. 6 indexed citations
7.
Chung, Yuan‐Chiang, Chin‐Hui Chen, Yu-Ting Tsai, et al.. (2017). Litchi seed extract inhibits epidermal growth factor receptor signaling and growth of Two Non-small cell lung carcinoma cells. BMC Complementary and Alternative Medicine. 17(1). 16–16. 20 indexed citations
8.
Yang, Cheng‐Hsien, et al.. (2015). Cost‐Effective Hierarchical Catalysts for Promoting Hydrogen Release from Complex Hydrides. ChemSusChem. 8(16). 2713–2718. 7 indexed citations
9.
Chung, Yuan‐Chiang, et al.. (2014). Rab11 regulates E-cadherin expression and induces cell transformation in colorectal carcinoma. BMC Cancer. 14(1). 587–587. 41 indexed citations
10.
Chung, Yuan‐Chiang, et al.. (2013). The Inhibitory Effect of Ellagic Acid on Cell Growth of Ovarian Carcinoma Cells. Evidence-based Complementary and Alternative Medicine. 2013. 1–12. 71 indexed citations
11.
Hsu, Chih‐Ping, Chih‐Cheng Lin, Chiu-Chen Huang, et al.. (2012). Induction of Apoptosis and Cell Cycle Arrest in Human Colorectal Carcinoma by Litchi Seed Extract. SHILAP Revista de lepidopterología. 2012. 1–7. 32 indexed citations
12.
Sung, Tzu-Ying, et al.. (2011). The ACR11 encodes a novel type of chloroplastic ACT domain repeat protein that is coordinately expressed with GLN2 in Arabidopsis. BMC Plant Biology. 11(1). 118–118. 24 indexed citations
13.
Chung, Yuan‐Chiang, Chiu-Chen Huang, Chin‐Hui Chen, et al.. (2011). Grape-Seed Procyanidins Inhibit the In Vitro Growth and Invasion of Pancreatic Carcinoma Cells. Pancreas. 41(3). 447–454. 26 indexed citations
14.
Chung, Yuan‐Chiang, et al.. (2010). The effect of Longan seed polyphenols on colorectal carcinoma cells. European Journal of Clinical Investigation. 40(8). 713–721. 50 indexed citations
15.
Hsu, Chih‐Ping, et al.. (2010). Longan Flower Extract Inhibits the Growth of Colorectal Carcinoma. Nutrition and Cancer. 62(2). 229–236. 20 indexed citations
16.
Hsu, Chih‐Ping, et al.. (2010). Pinolenic acid inhibits human breast cancer MDA-MB-231 cell metastasis in vitro. Food Chemistry. 126(4). 1708–1715. 36 indexed citations
17.
Hsu, Chih‐Ping, Yung‐Liang Chen, Chiu-Chen Huang, et al.. (2010). Anti-interleukin-6 receptor antibody inhibits the progression in human colon carcinoma cells. European Journal of Clinical Investigation. 41(3). 277–284. 38 indexed citations
18.
Lai, Ming‐Tsung, Yuan‐Chiang Chung, Chih‐Ping Hsu, et al.. (2002). Association of overexpressed proline‐directed protein kinase FA with chemoresistance, invasion, and recurrence in patients with bladder carcinoma. Cancer. 95(4). 775–783. 6 indexed citations
19.
Chung, Yuan‐Chiang, et al.. (2002). Association of proline‐directed protein kinase FA with tumorigenesis, invasion, and poor prognosis of human colon carcinoma. Cancer. 95(9). 1840–1847. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Govindaraj Sharmila Breakdown of academic impact, for papers by Yann Schneider Breakdown of academic impact, for papers by Elżbieta Hrabec Breakdown of academic impact, for papers by Lokesh Dalasanur Nagaprashantha Breakdown of academic impact, for papers by Andrew Hitron Breakdown of academic impact, for papers by Mohamed R. Akl Breakdown of academic impact, for papers by Marina Orlandi Breakdown of academic impact, for papers by Jing-Pin Lin Breakdown of academic impact, for papers by Jae In Jung Breakdown of academic impact, for papers by Ratana Banjerdpongchai
Rankless by CCL
2026